Enric Esplugues

Enric Esplugues

Auto-generated profile, based on publicly available information

Enric Esplugues

Molecular and Cellular Immunology Laboratory, Centro de Investigación Príncipe Felipe (CIPF), Valencia, Spain

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 April 2015 in Nature
Verified
Journal Article
Closed access
PDF file
NGNicola Gagliani
Nicola Gagliani
MVMaria Carolina Amezcua Vesely
Maria Carolina Amezcua Vesely
AIAndrea Iseppon
Andrea Iseppon
LBLeonie Brockmann
Leonie Brockmann
HXHao Xu
Hao Xu
RFRichard A. Flavell
Richard A. Flavell

17 July 2011 in Nature
Verified
Journal Article
Open access
PDF file
EEEnric Esplugues
Enric Esplugues
Samuel HuberSamuel Huber
Samuel Huber
NGNicola Gagliani
Nicola Gagliani
AHAnja Erika Hauser
Anja Erika Hauser
TTTerrence Town
Terrence Town
RFRichard A. Flavell
Richard A. Flavell
Interleukin-17-producing T helper (TH17) cells serve an important role in the immune system, but are strongly implicated in the pathogenesis of numerous autoimmune diseases including rheumatoid arthritis and multiple sclerosis. How the immune system controls TH17 cells in vivo remains unclear. Using mice in which tolerance was induced by CD3-specific antibody, a model of sepsis and influenza A viral infection, Esplugues et al. demonstrate that TH17 cells are kept in check by redirecting the cells to the small intestine where they are eliminated or re-programmed to acquire immunosuppressive and regulatory properties. This work identifies the gastrointestinal tract as a site for control of TH17 cells. Interleukin (IL)-17-producing T helper cells (TH17) are a recently identified CD4+ T cell subset distinct from T helper type 1 (TH1) and T helper type 2 (TH2) cells1. TH17 cells can drive antigen-specific autoimmune diseases and are considered the main population of pathogenic T cells driving experimental autoimmune encephalomyelitis (EAE)2, the mouse model for multiple sclerosis. The factors that are needed for the generation of TH17 cells have been well characterized3,4,5,6. However, where and how the immune system controls TH17 cells in vivo remains unclear. Here, by using a model of tolerance induced by CD3-specific antibody, a model of sepsis and influenza A viral infection (H1N1), we show that pro-inflammatory TH17 cells can be redirected to and controlled in the small intestine. TH17-specific IL-17A secretion induced expression of the chemokine CCL20 in the small intestine, facilitating the migration of these cells specifically to the small intestine via the CCR6/CCL20 axis. Moreover, we found that TH17 cells are controlled by two different mechanisms in the small intestine: first, they are eliminated via the intestinal lumen; second, pro-inflammatory TH17 cells simultaneously acquire a regulatory phenotype with in vitro and in vivo immune-suppressive properties (rTH17). These results identify mechanisms limiting TH17 cell pathogenicity and implicate the gastrointestinal tract as a site for control of TH17 cells.

16 May 2011 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
Alberto DavalosAlberto Davalos
Alberto Davalos
LGLeigh Goedeke
Leigh Goedeke
PSPeter Smibert
Peter Smibert
Cristina M. Ramírez HidalgoCristina M. Ramírez Hidalgo
Cristina M. Ramírez Hidalgo
NWNikhil P. Warrier
Nikhil P. Warrier
CFCarlos Fernández-Hernando
Carlos Fernández-Hernando
Cellular imbalances of cholesterol and fatty acid metabolism result in pathological processes, including atherosclerosis and metabolic syndrome. Recent work from our group and others has shown that the intronic microRNAs hsa-miR-33a and hsa-miR-33b are located within the sterol regulatory element-binding protein-2 and -1 genes, respectively, and regulate cholesterol homeostasis in concert with their host genes. Here, we show that miR-33a and -b also regulate genes involved in fatty acid metabolism and insulin signaling. miR-33a and -b target key enzymes involved in the regulation of fatty acid oxidation, including carnitine O -octaniltransferase, carnitine palmitoyltransferase 1A, hydroxyacyl-CoA-dehydrogenase, Sirtuin 6 (SIRT6), and AMP kinase subunit-α. Moreover, miR-33a and -b also target the insulin receptor substrate 2, an essential component of the insulin-signaling pathway in the liver. Overexpression of miR-33a and -b reduces both fatty acid oxidation and insulin signaling in hepatic cell lines, whereas inhibition of endogenous miR-33a and -b increases these two metabolic pathways. Together, these data establish that miR-33a and -b regulate pathways controlling three of the risk factors of metabolic syndrome, namely levels of HDL, triglycerides, and insulin signaling, and suggest that inhibitors of miR-33a and -b may be useful in the treatment of this growing health concern.

1 April 2011 in Immunity
Verified
Journal Article
Closed access
Samuel HuberSamuel Huber
Samuel Huber
NGNicola Gagliani
Nicola Gagliani
EEEnric Esplugues
Enric Esplugues
WOWilliam O'COnnor
William O'COnnor
FHFrancis J. Huber
Francis J. Huber
RFRichard A. Flavell
Richard A. Flavell

29 August 2014 in Science
Verified
Journal Article
Closed access
PDF file
ZSZiv Shulman
Ziv Shulman
AGAlexander D. Gitlin
Alexander D. Gitlin
JWJason S. Weinstein
Jason S. Weinstein
BLBegoña Lainez
Begoña Lainez
EEEnric Esplugues
Enric Esplugues
MNMichel C. Nussenzweig
Michel C. Nussenzweig
T and B cells' intricate molecular dance: Generating high-affinity antibodies to fight infection is no easy task. To do so requires multiple steps, including T cells interacting with antibody-producing B cells in lymph nodes. These interactions select B cells expressing high-affinity antibodies for further proliferation, ensuring that the immune response generates high-affinity antibodies in large quantities. Shulman et al. use fluorescent live-cell imaging in mice to determine the molecular details of these interactions. They find that T cells engage B cells in short-lived mobile contacts during selection. These contacts cause T cells to flux calcium and produce proteins called cytokines, which probably drive B cells to proliferate and produce high-affinity antibodies. Science , this issue p. 1058

29 August 2016 in Nature Immunology
Verified
Journal Article
Open access
PDF file
JWJason S Weinstein
Jason S Weinstein
EHEdward I Herman
Edward I Herman
BLBegoña Lainez
Begoña Lainez
PLPaula Licona-Limón
Paula Licona-Limón
EEEnric Esplugues
Enric Esplugues
JCJoe Craft
Joe Craft
Craft and colleagues show that follicular helper T cells progress through transcriptionally and functionally distinct stages that provide specific signals for germinal center regulation. Germinal center (GC) B cells undergo affinity selection, which depends on interactions with CD4+ follicular helper T cells (TFH cells). We found that TFH cells progressed through transcriptionally and functionally distinct stages and provided differential signals for GC regulation. They initially localized proximally to mutating B cells, secreted interleukin 21 (IL-21), induced expression of the transcription factor Bcl-6 and selected high-affinity B cell clones. As the GC response evolved, TFH cells extinguished IL-21 production and switched to IL-4 production, showed robust expression of the co-stimulatory molecule CD40L, and promoted the development of antibody-secreting B cells via upregulation of the transcription factor Blimp-1. Thus, TFH cells in the B cell follicle progressively differentiate through stages of localization, cytokine production and surface ligand expression to 'fine tune' the GC reaction.